Cohance Lifesciences Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 454.6 as of 05 May 15:30 . The P/E Ratio of Cohance Lifesciences Ltd changed from 34.8 on March 2021 to 110.3 on March 2025 . This represents a CAGR of 25.95% over 5 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 21.6 on March 2021 to 38.3 on March 2025 . This represents a CAGR of 12.14% over 5 years The Market Cap of Cohance Lifesciences Ltd changed from ₹ 12611 crore on March 2021 to ₹ 29524 crore on March 2025 . This represents a CAGR of 18.55% over 5 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 9688 crore on March 2021 to ₹ 25253 crore on March 2025 . This represents a CAGR of 21.12% over 5 years The revenue of Cohance Lifesciences Ltd for the Dec '25 is ₹ 550.71 crore as compare to the Sep '25 revenue of ₹ 571.17 crore. This represent the decline of -3.58% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 1083 crore as compare to the Sep '25 revenue of ₹ 1100 crore. This represent the decline of -1.57% The ebitda of Cohance Lifesciences Ltd for the Dec '25 is ₹ 96.65 crore as compare to the Sep '25 ebitda of ₹ 136.55 crore. This represent the decline of -29.22% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 314.1 crore as compare to the Sep '25 ebitda of ₹ 324.94 crore. This represent the decline of -3.34% The net profit of Cohance Lifesciences Ltd changed from ₹ 75.37 crore to ₹ 29.02 crore over 7 quarters. This represents a CAGR of -42.04% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 176.83 crore to ₹ 197.89 crore over 7 quarters. This represents a CAGR of 6.64% The Dividend Payout of Cohance Lifesciences Ltd changed from 16.5 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 28.53 % on March 2021 to 36.98 % on March 2025 . This represents a CAGR of 5.33% over 5 years .

About Cohance Lifesciences Ltd

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018.
The name of the Company has been changed to Cohance Lifesciences Limited w.e.f.
May 7, 2025.
Cohance Lifesciences Ltd is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

FAQs for the comparison of Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Cohance Lifesciences Ltd is 17,391 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 33,656 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of May 5, 2026, the Cohance Lifesciences Ltd stock price is INR ₹454.6. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹2096.2.

How do dividend payouts of Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.